Report Detail

Service & Software Global Pharmaceutical Impurity Analysis Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4757344
  • |
  • 13 October, 2026
  • |
  • Global
  • |
  • 111 Pages
  • |
  • GIR
  • |
  • Service & Software

According to our (Global Info Research) latest study, the global Pharmaceutical Impurity Analysis Service market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Pharmaceutical Impurity Analysis Service is a quality testing service for pharmaceutical products. This service is designed to detect possible harmful impurities in pharmaceutical products to ensure the safety and effectiveness of the products. This service is very important for quality control and supervision of pharmaceutical companies and helps ensure the safety and effectiveness of patients" medications.
This report is a detailed and comprehensive analysis for global Pharmaceutical Impurity Analysis Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pharmaceutical Impurity Analysis Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global Pharmaceutical Impurity Analysis Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Pharmaceutical Impurity Analysis Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Pharmaceutical Impurity Analysis Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Impurity Analysis Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Impurity Analysis Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Intertek, Creative Proteomics, Emery Pharma, Agilent, Vimta, Alfa Chemistry, Eurofins, Alera Labs, Impact Analytical, Leeder Analytical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Pharmaceutical Impurity Analysis Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Organic Impurity Analysis
Inorganic Impurity Analysis
Residual Solvent Analysis
Others
Market segment by Application
Pharmaceutical Industry
Agriculture
Biotechnology
Others
Market segment by players, this report covers
Intertek
Creative Proteomics
Emery Pharma
Agilent
Vimta
Alfa Chemistry
Eurofins
Alera Labs
Impact Analytical
Leeder Analytical
Nelson Labs
Reading Scientific Services
Regis Technologies
Selvita
SGS
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pharmaceutical Impurity Analysis Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical Impurity Analysis Service, with revenue, gross margin, and global market share of Pharmaceutical Impurity Analysis Service from 2021 to 2026.
Chapter 3, the Pharmaceutical Impurity Analysis Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Pharmaceutical Impurity Analysis Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical Impurity Analysis Service.
Chapter 13, to describe Pharmaceutical Impurity Analysis Service research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Pharmaceutical Impurity Analysis Service by Type
    • 1.3.1 Overview: Global Pharmaceutical Impurity Analysis Service Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Pharmaceutical Impurity Analysis Service Consumption Value Market Share by Type in 2025
    • 1.3.3 Organic Impurity Analysis
    • 1.3.4 Inorganic Impurity Analysis
    • 1.3.5 Residual Solvent Analysis
    • 1.3.6 Others
  • 1.4 Global Pharmaceutical Impurity Analysis Service Market by Application
    • 1.4.1 Overview: Global Pharmaceutical Impurity Analysis Service Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Pharmaceutical Industry
    • 1.4.3 Agriculture
    • 1.4.4 Biotechnology
    • 1.4.5 Others
  • 1.5 Global Pharmaceutical Impurity Analysis Service Market Size & Forecast
  • 1.6 Global Pharmaceutical Impurity Analysis Service Market Size and Forecast by Region
    • 1.6.1 Global Pharmaceutical Impurity Analysis Service Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Pharmaceutical Impurity Analysis Service Market Size by Region, (2021-2032)
    • 1.6.3 North America Pharmaceutical Impurity Analysis Service Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Pharmaceutical Impurity Analysis Service Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size and Prospect (2021-2032)
    • 1.6.6 South America Pharmaceutical Impurity Analysis Service Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Intertek
    • 2.1.1 Intertek Details
    • 2.1.2 Intertek Major Business
    • 2.1.3 Intertek Pharmaceutical Impurity Analysis Service Product and Solutions
    • 2.1.4 Intertek Pharmaceutical Impurity Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Intertek Recent Developments and Future Plans
  • 2.2 Creative Proteomics
    • 2.2.1 Creative Proteomics Details
    • 2.2.2 Creative Proteomics Major Business
    • 2.2.3 Creative Proteomics Pharmaceutical Impurity Analysis Service Product and Solutions
    • 2.2.4 Creative Proteomics Pharmaceutical Impurity Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Creative Proteomics Recent Developments and Future Plans
  • 2.3 Emery Pharma
    • 2.3.1 Emery Pharma Details
    • 2.3.2 Emery Pharma Major Business
    • 2.3.3 Emery Pharma Pharmaceutical Impurity Analysis Service Product and Solutions
    • 2.3.4 Emery Pharma Pharmaceutical Impurity Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Emery Pharma Recent Developments and Future Plans
  • 2.4 Agilent
    • 2.4.1 Agilent Details
    • 2.4.2 Agilent Major Business
    • 2.4.3 Agilent Pharmaceutical Impurity Analysis Service Product and Solutions
    • 2.4.4 Agilent Pharmaceutical Impurity Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Agilent Recent Developments and Future Plans
  • 2.5 Vimta
    • 2.5.1 Vimta Details
    • 2.5.2 Vimta Major Business
    • 2.5.3 Vimta Pharmaceutical Impurity Analysis Service Product and Solutions
    • 2.5.4 Vimta Pharmaceutical Impurity Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Vimta Recent Developments and Future Plans
  • 2.6 Alfa Chemistry
    • 2.6.1 Alfa Chemistry Details
    • 2.6.2 Alfa Chemistry Major Business
    • 2.6.3 Alfa Chemistry Pharmaceutical Impurity Analysis Service Product and Solutions
    • 2.6.4 Alfa Chemistry Pharmaceutical Impurity Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Alfa Chemistry Recent Developments and Future Plans
  • 2.7 Eurofins
    • 2.7.1 Eurofins Details
    • 2.7.2 Eurofins Major Business
    • 2.7.3 Eurofins Pharmaceutical Impurity Analysis Service Product and Solutions
    • 2.7.4 Eurofins Pharmaceutical Impurity Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Eurofins Recent Developments and Future Plans
  • 2.8 Alera Labs
    • 2.8.1 Alera Labs Details
    • 2.8.2 Alera Labs Major Business
    • 2.8.3 Alera Labs Pharmaceutical Impurity Analysis Service Product and Solutions
    • 2.8.4 Alera Labs Pharmaceutical Impurity Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Alera Labs Recent Developments and Future Plans
  • 2.9 Impact Analytical
    • 2.9.1 Impact Analytical Details
    • 2.9.2 Impact Analytical Major Business
    • 2.9.3 Impact Analytical Pharmaceutical Impurity Analysis Service Product and Solutions
    • 2.9.4 Impact Analytical Pharmaceutical Impurity Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Impact Analytical Recent Developments and Future Plans
  • 2.10 Leeder Analytical
    • 2.10.1 Leeder Analytical Details
    • 2.10.2 Leeder Analytical Major Business
    • 2.10.3 Leeder Analytical Pharmaceutical Impurity Analysis Service Product and Solutions
    • 2.10.4 Leeder Analytical Pharmaceutical Impurity Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Leeder Analytical Recent Developments and Future Plans
  • 2.11 Nelson Labs
    • 2.11.1 Nelson Labs Details
    • 2.11.2 Nelson Labs Major Business
    • 2.11.3 Nelson Labs Pharmaceutical Impurity Analysis Service Product and Solutions
    • 2.11.4 Nelson Labs Pharmaceutical Impurity Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Nelson Labs Recent Developments and Future Plans
  • 2.12 Reading Scientific Services
    • 2.12.1 Reading Scientific Services Details
    • 2.12.2 Reading Scientific Services Major Business
    • 2.12.3 Reading Scientific Services Pharmaceutical Impurity Analysis Service Product and Solutions
    • 2.12.4 Reading Scientific Services Pharmaceutical Impurity Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Reading Scientific Services Recent Developments and Future Plans
  • 2.13 Regis Technologies
    • 2.13.1 Regis Technologies Details
    • 2.13.2 Regis Technologies Major Business
    • 2.13.3 Regis Technologies Pharmaceutical Impurity Analysis Service Product and Solutions
    • 2.13.4 Regis Technologies Pharmaceutical Impurity Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Regis Technologies Recent Developments and Future Plans
  • 2.14 Selvita
    • 2.14.1 Selvita Details
    • 2.14.2 Selvita Major Business
    • 2.14.3 Selvita Pharmaceutical Impurity Analysis Service Product and Solutions
    • 2.14.4 Selvita Pharmaceutical Impurity Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Selvita Recent Developments and Future Plans
  • 2.15 SGS
    • 2.15.1 SGS Details
    • 2.15.2 SGS Major Business
    • 2.15.3 SGS Pharmaceutical Impurity Analysis Service Product and Solutions
    • 2.15.4 SGS Pharmaceutical Impurity Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 SGS Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Pharmaceutical Impurity Analysis Service Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Pharmaceutical Impurity Analysis Service by Company Revenue
    • 3.2.2 Top 3 Pharmaceutical Impurity Analysis Service Players Market Share in 2025
    • 3.2.3 Top 6 Pharmaceutical Impurity Analysis Service Players Market Share in 2025
  • 3.3 Pharmaceutical Impurity Analysis Service Market: Overall Company Footprint Analysis
    • 3.3.1 Pharmaceutical Impurity Analysis Service Market: Region Footprint
    • 3.3.2 Pharmaceutical Impurity Analysis Service Market: Company Product Type Footprint
    • 3.3.3 Pharmaceutical Impurity Analysis Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Pharmaceutical Impurity Analysis Service Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Pharmaceutical Impurity Analysis Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Pharmaceutical Impurity Analysis Service Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Pharmaceutical Impurity Analysis Service Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Pharmaceutical Impurity Analysis Service Consumption Value by Type (2021-2032)
  • 6.2 North America Pharmaceutical Impurity Analysis Service Market Size by Application (2021-2032)
  • 6.3 North America Pharmaceutical Impurity Analysis Service Market Size by Country
    • 6.3.1 North America Pharmaceutical Impurity Analysis Service Consumption Value by Country (2021-2032)
    • 6.3.2 United States Pharmaceutical Impurity Analysis Service Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Pharmaceutical Impurity Analysis Service Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Pharmaceutical Impurity Analysis Service Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Pharmaceutical Impurity Analysis Service Consumption Value by Type (2021-2032)
  • 7.2 Europe Pharmaceutical Impurity Analysis Service Consumption Value by Application (2021-2032)
  • 7.3 Europe Pharmaceutical Impurity Analysis Service Market Size by Country
    • 7.3.1 Europe Pharmaceutical Impurity Analysis Service Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Pharmaceutical Impurity Analysis Service Market Size and Forecast (2021-2032)
    • 7.3.3 France Pharmaceutical Impurity Analysis Service Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Pharmaceutical Impurity Analysis Service Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Pharmaceutical Impurity Analysis Service Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Pharmaceutical Impurity Analysis Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Pharmaceutical Impurity Analysis Service Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Pharmaceutical Impurity Analysis Service Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size by Region
    • 8.3.1 Asia-Pacific Pharmaceutical Impurity Analysis Service Consumption Value by Region (2021-2032)
    • 8.3.2 China Pharmaceutical Impurity Analysis Service Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Pharmaceutical Impurity Analysis Service Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Pharmaceutical Impurity Analysis Service Market Size and Forecast (2021-2032)
    • 8.3.5 India Pharmaceutical Impurity Analysis Service Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Pharmaceutical Impurity Analysis Service Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Pharmaceutical Impurity Analysis Service Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Pharmaceutical Impurity Analysis Service Consumption Value by Type (2021-2032)
  • 9.2 South America Pharmaceutical Impurity Analysis Service Consumption Value by Application (2021-2032)
  • 9.3 South America Pharmaceutical Impurity Analysis Service Market Size by Country
    • 9.3.1 South America Pharmaceutical Impurity Analysis Service Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Pharmaceutical Impurity Analysis Service Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Pharmaceutical Impurity Analysis Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Pharmaceutical Impurity Analysis Service Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Pharmaceutical Impurity Analysis Service Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Country
    • 10.3.1 Middle East & Africa Pharmaceutical Impurity Analysis Service Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Pharmaceutical Impurity Analysis Service Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Pharmaceutical Impurity Analysis Service Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Pharmaceutical Impurity Analysis Service Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Pharmaceutical Impurity Analysis Service Market Drivers
  • 11.2 Pharmaceutical Impurity Analysis Service Market Restraints
  • 11.3 Pharmaceutical Impurity Analysis Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Pharmaceutical Impurity Analysis Service Industry Chain
  • 12.2 Pharmaceutical Impurity Analysis Service Upstream Analysis
  • 12.3 Pharmaceutical Impurity Analysis Service Midstream Analysis
  • 12.4 Pharmaceutical Impurity Analysis Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Pharmaceutical Impurity Analysis Service. Industry analysis & Market Report on Pharmaceutical Impurity Analysis Service is a syndicated market report, published as Global Pharmaceutical Impurity Analysis Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Pharmaceutical Impurity Analysis Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report